5,483
Views
70
CrossRef citations to date
0
Altmetric
Extra View

Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer

ORCID Icon, , &
Pages 737-745 | Received 16 Aug 2016, Accepted 21 Sep 2016, Published online: 30 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yong-Mei Jin, Ying Ye, Wen-Qing Bao, Yang Tong, Shu-Bin Ni, Jian-Ping Liu & Bin Zhao. (2022) CACNA1B facilitates breast cancer cell growth and migration by regulating cyclin D1 and EMT: the implication of CACNA1B in breast cancer. Journal of Receptors and Signal Transduction 42:1, pages 1-8.
Read now
Salma El-Habashy, Hoda Eltaher, Ahmed Gaballah, Radwa Mehanna & Amal H El-Kamel. (2021) Biomaterial-Based Nanocomposite for Osteogenic Repurposing of Doxycycline. International Journal of Nanomedicine 16, pages 1103-1126.
Read now
Ruixin Jia, Lesheng Teng, Lingyu Gao, Ting Su, Lu Fu, Zhidong Qiu & Ye Bi. (2021) Advances in Multiple Stimuli-Responsive Drug-Delivery Systems for Cancer Therapy. International Journal of Nanomedicine 16, pages 1525-1551.
Read now

Articles from other publishers (67)

Divya Ajmeera & Rajanna Ajumeera. (2024) Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance. Genes & Diseases 11:1, pages 148-175.
Crossref
Fabrizio Fontana, Chiara Macchi, Martina Anselmi, Alessandra Stefania Rizzuto, Massimiliano Ruscica & Patrizia Limonta. (2024) PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1870:1, pages 166897.
Crossref
Ivonne Olmedo, Daniela Martínez, Javiera Carrasco-Rojas & José A. Jara. (2023) Mitochondria in oral cancer stem cells: Unraveling the potential drug targets for new and old drugs. Life Sciences 331, pages 122065.
Crossref
Jiayu Li, Yuan Qin, Chenhao Zhao, Zhi Zhang & Zhiruo Zhou. (2023) Tetracycline antibiotics: Potential anticancer drugs. European Journal of Pharmacology 956, pages 175949.
Crossref
Pegah Farhadi, Shiva Irani, Mohammadreza Gholami & Kamran Mansouri. (2023) A metabolism targeting three-pronged attack significantly attenuates breast cancer stem cell related markers toward therapeutic application. Biomedicine & Pharmacotherapy 161, pages 114496.
Crossref
Qitong Wu & Dipali Sharma. (2023) Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy. Cells 12:8, pages 1156.
Crossref
Anton Shetnev, Marina Tarasenko, Valentina Kotlyarova, Sergey Baykov, Kirill Geyl, Svetlana Kasatkina, Nikolina Sibinčić, Vladimir Sharoyko, Elizaveta V. Rogacheva & Liudmila A. Kraeva. (2022) External oxidant-free and transition metal-free synthesis of 5-amino-1,2,4-thiadiazoles as promising antibacterials against ESKAPE pathogen strains. Molecular Diversity 27:2, pages 651-666.
Crossref
Rohan Wedam, Yoshimi Endo Greer, David J. Wisniewski, Sarah Weltz, Manjari Kundu, Donna Voeller & Stanley Lipkowitz. (2023) Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer. Cancers 15:7, pages 1936.
Crossref
Marina A Senchukova. (2023) Genetic heterogeneity of colorectal cancer and the microbiome. World Journal of Gastrointestinal Oncology 15:3, pages 443-463.
Crossref
Praveen Prathapan. (2023) Magic bullets, magic shields, and antimicrobials in between. Pharmaceutical Science Advances 1:1, pages 100002.
Crossref
Huijun Zhao, Gregory Pond, Demetrios Simos, Zhou Wang, Susan Robertson, Gurmit Singh, Lisa Vandermeer, Mark Clemons & Christina Lynn Addison. (2023) Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone Metastases from Breast Cancer. Cancers 15:3, pages 571.
Crossref
Daria S. Chulpanova, Albert A. Rizvanov & Valeriya V. Solovyeva. (2022) The Role of Cancer Stem Cells and Their Extracellular Vesicles in the Modulation of the Antitumor Immunity. International Journal of Molecular Sciences 24:1, pages 395.
Crossref
Chenghao Zhanghuang, Zhaoxia Zhang, Tao Mi, Jinkui Wang, Liming Jin, Jiayan Liu, Maoxian Li, Mujie Li, Xin Wu, Zhang Wang & Dawei He. (2022) Doxycycline Hydrochloride Regulates Cytoskeletal Rearrangement and Epithelial-To-Mesenchymal Transition in Malignant Rhabdoid Tumour of the Kidney. BioMed Research International 2022, pages 1-21.
Crossref
Xirui Duan, Maochao Luo, Jian Li, Zhisen Shen & Ke Xie. (2022) Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition. Frontiers in Oncology 12.
Crossref
Khadija Shahab Turabi, Ankita Deshmukh, Sayan Paul, Dayanand Swami, Shafina Siddiqui, Urwashi Kumar, Shreelekha Naikar, Shine Devarajan, Soumya Basu, Manash K. Paul & Jyotirmoi Aich. (2022) Drug repurposing—an emerging strategy in cancer therapeutics. Naunyn-Schmiedeberg's Archives of Pharmacology 395:10, pages 1139-1158.
Crossref
Emma Phillips, Jörg Balss, Frederic Bethke, Stefan Pusch, Stefan Christen, Thomas Hielscher, Martina Schnölzer, Michael N. C. Fletcher, Antje Habel, Claudia Tessmer, Lisa-Marie Brenner, Mona Göttmann, David Capper, Christel Herold-Mende, Andreas von Deimling, Sarah-Maria Fendt & Violaine Goidts. (2022) PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma. Oncogenesis 11:1.
Crossref
Daniel Florin Pancu, Robert Cosmin Racea, Ioana Macasoi, Cristian Andrei Sarau, Iulia Pinzaru, Marioara Poenaru, Laura-Cristina Rusu, Cristina Adriana Dehelean & Stefania Dinu. (2022) Assessment of the In Vitro Cytotoxic Profile of Two Broad-Spectrum Antibiotics—Tetracycline and Ampicillin—On Pharyngeal Carcinoma Cells. Medicina 58:9, pages 1289.
Crossref
Shipra Singhal, Priyal Maheshwari, Praveen Thaggikuppe Krishnamurthy & Vaishali M. Patil. (2022) Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics. Anti-Cancer Agents in Medicinal Chemistry 22:15, pages 2726-2756.
Crossref
Jiang Shan, Ding Xiaoqian, Li Xia, Wang Yu, Zheng Zhilong, Shi Zhihui & Qin Yanjie. (2022) Oxidative stress, autophagy, and apoptosis induced by doxycycline in loach fin cells in vitro. Science of The Total Environment 839, pages 156379.
Crossref
Antonino Passaniti, Myoung Sook Kim, Brian M. Polster & Paul Shapiro. (2022) Targeting mitochondrial metabolism for metastatic cancer therapy. Molecular Carcinogenesis 61:9, pages 827-838.
Crossref
Jacek Wojcierowski, Karolina Olszewska-Bożek, Ewa Kolobius, Magdalena Wojcierowska-Litwin & Szymon Zmorzyński. (2022) Properties of cancer stem cells. Diagnostyka Laboratoryjna 57:4, pages 213-224.
Crossref
Hua Wang, Yinfeng Tan, Hao Jia, Danqi Liu & Rangru Liu. (2022) Posaconazole inhibits the stemness of cancer stem-like cells by inducing autophagy and suppressing the Wnt/β-catenin/survivin signaling pathway in glioblastoma. Frontiers in Pharmacology 13.
Crossref
Marina Ibragimova, Matvey Tsyganov & Nikolai Litviakov. (2022) Tumour Stem Cells in Breast Cancer. International Journal of Molecular Sciences 23:9, pages 5058.
Crossref
Imren Alioglu, Ilias Tsochantaridis, Aglaia Pappa, Egemen Dere & Ferda Ari. (2022) Zn(II) 5,5‐Diethylbarbiturate Complex Selectively Induces Apoptosis in Breast Cancer and Breast Cancer Stem‐Like Cells. Chemistry & Biodiversity 19:4.
Crossref
Yi-Fong Chen, Yung-Ning Yang, Hung-Ru Chu, Tung-Yung Huang, Shwu-Huey Wang, Han-Yu Chen, Zi-Lin Li, Yu-Chen S. H. Yang, Hung-Yun Lin, Aleck Hercbergs, Jacqueline Whang-Peng, Kuan Wang & Paul J. Davis. (2022) Role of Integrin αvβ3 in Doxycycline-Induced Anti-Proliferation in Breast Cancer Cells. Frontiers in Cell and Developmental Biology 10.
Crossref
Kimia Ghasemi & Kosar Ghasemi. (2022) A Brief look at antitumor effects of doxycycline in the treatment of colorectal cancer and combination therapies. European Journal of Pharmacology 916, pages 174593.
Crossref
Jakub Rok, Zuzanna Rzepka, Justyna Kowalska, Klaudia Banach, Artur Beberok & Dorota Wrześniok. (2022) The Anticancer Potential of Doxycycline and Minocycline—A Comparative Study on Amelanotic Melanoma Cell Lines. International Journal of Molecular Sciences 23:2, pages 831.
Crossref
Laura Sangaré, Alecia Divita, Marko Rehn, Michelle McNamara & Kimberly A. Lowe. (2021) Navigating metastatic colorectal treatment options in the USA: a survey of patient acceptance of skin toxicities associated with Vectibix. Supportive Care in Cancer 29:11, pages 6731-6740.
Crossref
Weiwei Sun, Bin Zhang, Qingli Bie, Na Ma, Na Liu & Zewei Shao. (2021) The Role of RNA Methylation in Regulating Stem Cell Fate and Function-Focus on m6A. Stem Cells International 2021, pages 1-13.
Crossref
Xiaofan Jiang, Lu Liang, Guanglei Chen & Caigang Liu. (2021) Modulation of Immune Components on Stem Cell and Dormancy in Cancer. Cells 10:11, pages 2826.
Crossref
Bo Wang, Jinsong Ao, Xiaoyan Li, Weimin Yu, Dan Yu & Chengjun Qiu. (2021) Doxycycline sensitizes renal cell carcinoma to chemotherapy by preferentially inhibiting mitochondrial translation. Journal of International Medical Research 49:10, pages 030006052110443.
Crossref
Roberto Vendramin, Vicky Katopodi, Sonia Cinque, Angelina Konnova, Zorica Knezevic, Sara Adnane, Yvessa Verheyden, Panagiotis Karras, Ewout Demesmaeker, Francesca M. Bosisio, Lukas Kucera, Jan Rozman, Ivan Gladwyn-Ng, Lara Rizzotto, Erik Dassi, Stefania Millevoi, Oliver Bechter, Jean-Christophe Marine & Eleonora Leucci. (2021) Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma. Journal of Experimental Medicine 218:9.
Crossref
Vahid Mohammadkarimi, Negar Azarpira, Zahra Ghanbarinasab, Pezhman Shiri, Fatemeh Sadat Dehghani, Amin Nakhostin-Ansari, Fatemeh Tayyebi-Khorrami, Amir Atapour & Ali Mohammad Amani. (2021) Synthesis of Silver-Doxycycline Complex Nanoparticles and Their Biological Evaluation on MCF-7 Cell Line of the Breast Cancer. Journal of Chemistry 2021, pages 1-8.
Crossref
Sahib Zada, Jin Seok Hwang, Mahmoud Ahmed, Trang Huyen Lai, Trang Minh Pham, Omar Elashkar & Deok Ryong Kim. (2021) Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:1, pages 188565.
Crossref
Christina Pfab, Luisa Schnobrich, Samir Eldnasoury, André Gessner & Nahed El-Najjar. (2021) Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?. Cancers 13:13, pages 3193.
Crossref
Félix A. Urra, Sebastián Fuentes-Retamal, Charlotte Palominos & Ramiro Araya-Maturana. 2021. 1 43 .
María Valero-Muñoz, Richard M. Wilson, Rosa Bretón-Romero, Dominique Croteau, David C. Seldin & Flora Sam. (2020) Doxycycline decreases amyloidogenic light chain-induced autophagy in isolated primary cardiac myocytes. International Journal of Cardiology 321, pages 133-136.
Crossref
Mabel Catalán, Ivonne Olmedo, Jennifer Faúndez & José A. Jara. (2020) Medicinal Chemistry Targeting Mitochondria: From New Vehicles and Pharmacophore Groups to Old Drugs with Mitochondrial Activity. International Journal of Molecular Sciences 21:22, pages 8684.
Crossref
Atsushi Tanabe & Hiroeki Sahara. (2020) The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells. Cancers 12:10, pages 2780.
Crossref
Sandra Cortez-Maya, Antonio Moreno-Herrera, Isidro Palos & Gildardo Rivera. (2020) Old Antiprotozoal Drugs: Are They Still Viable Options for Parasitic Infections or New Options for Other Diseases?. Current Medicinal Chemistry 27:32, pages 5403-5428.
Crossref
Béla Ózsvári, Luma G. Magalhães, Joe Latimer, Jussi Kangasmetsa, Federica Sotgia & Michael P. Lisanti. (2020) A Myristoyl Amide Derivative of Doxycycline Potently Targets Cancer Stem Cells (CSCs) and Prevents Spontaneous Metastasis, Without Retaining Antibiotic Activity. Frontiers in Oncology 10.
Crossref
Lia Walcher, Ann-Kathrin Kistenmacher, Huizhen Suo, Reni Kitte, Sarah Dluczek, Alexander Strauß, André-René Blaudszun, Tetyana Yevsa, Stephan Fricke & Uta Kossatz-Boehlert. (2020) Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Frontiers in Immunology 11.
Crossref
José Manuel García-Heredia & Amancio Carnero. (2020) Role of Mitochondria in Cancer Stem Cell Resistance. Cells 9:7, pages 1693.
Crossref
Vrajesh Pandya, John Maringa Githaka, Namrata Patel, Richard Veldhoen, Judith Hugh, Sambasivarao Damaraju, Todd McMullen, John Mackey & Ing Swie Goping. (2020) BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer. Cell Death & Disease 11:6.
Crossref
Jakub Rok, Marta Karkoszka, Zuzanna Rzepka, Michalina Respondek, Klaudia Banach, Artur Beberok & Dorota Wrześniok. (2020) Cytotoxic and proapoptotic effect of doxycycline – An in vitro study on the human skin melanoma cells. Toxicology in Vitro 65, pages 104790.
Crossref
Minal Garg. (2020) Epithelial Plasticity, Autophagy and Metastasis: Potential Modifiers of the Crosstalk to Overcome Therapeutic Resistance. Stem Cell Reviews and Reports 16:3, pages 503-510.
Crossref
Sas N. Dijk, Margherita Protasoni, Marilena Elpidorou, Albert M. Kroon & Jan-Willem Taanman. (2020) Mitochondria as target to inhibit proliferation and induce apoptosis of cancer cells: the effects of doxycycline and gemcitabine. Scientific Reports 10:1.
Crossref
Jens Henrik Norum, Oliver Frings, Maria Kasper, Helga Bergholtz, Helene Zell Thime, Åsa Bergström, Agneta Andersson, Raoul Kuiper, Erik Fredlund, Therese Sørlie & Rune Toftgård. (2019) GLI1‐induced mammary gland tumours are transplantable and maintain major molecular features. International Journal of Cancer 146:4, pages 1125-1138.
Crossref
Teresa Bernadette Steinbichler, Dragana Savic, József Dudás, Irma Kvitsaridze, Sergej Skvortsov, Herbert Riechelmann & Ira-Ida Skvortsova. (2020) Cancer stem cells and their unique role in metastatic spread. Seminars in Cancer Biology 60, pages 148-156.
Crossref
Vuyolwethu Khwaza, Zintle Mbese, Blessing A. Aderibigbe & Opeoluwa O. Oyedeji. 2020. Antibiotic Materials in Healthcare. Antibiotic Materials in Healthcare 11 32 .
Plabon K. Das, Md. A. Rakib, Jahan A. Khanam, Suja Pillai & Farhadul Islam. (2019) Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways. Current Stem Cell Research & Therapy 14:8, pages 669-682.
Crossref
Zhen Dong, Muhammad Nadeem Abbas, Saima Kausar, Jie Yang, Lin Li, Li Tan & Hongjuan Cui. (2019) Biological Functions and Molecular Mechanisms of Antibiotic Tigecycline in the Treatment of Cancers. International Journal of Molecular Sciences 20:14, pages 3577.
Crossref
Dandan CaoHoi-Hung CheungWai-Yee Chan. (2019) Doxycycline Masks the Genuine Effect of the Doxycycline-Inducible Transgene by Promoting Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells. Stem Cells and Development 28:13, pages 833-845.
Crossref
Anna Markowska, Joanna Kaysiewicz, Janina Markowska & Adam Huczyński. (2019) Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs. Bioorganic & Medicinal Chemistry Letters 29:13, pages 1549-1554.
Crossref
Ali Alaseem, Khalid Alhazzani, Priya Dondapati, Saad Alobid, Anupam Bishayee & Appu Rathinavelu. (2019) Matrix Metalloproteinases: A challenging paradigm of cancer management. Seminars in Cancer Biology 56, pages 100-115.
Crossref
Anton Shetnev, Sergey Baykov, Stanislav Kalinin, Alexandra Belova, Vladimir Sharoyko, Anton Rozhkov, Lev Zelenkov, Marina Tarasenko, Evgeny Sadykov, Mikhail Korsakov & Mikhail Krasavin. (2019) 1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer. International Journal of Molecular Sciences 20:7, pages 1699.
Crossref
Anton Misak, Lucia Kurakova, Eduard Goffa, Vlasta Brezova, Marian Grman, Elena Ondriasova, Miroslav Chovanec & Karol Ondrias. (2019) Sulfide (Na2S) and Polysulfide (Na2S2) Interacting with Doxycycline Produce/Scavenge Superoxide and Hydroxyl Radicals and Induce/Inhibit DNA Cleavage. Molecules 24:6, pages 1148.
Crossref
Briana C. Prager, Qi Xie, Shideng Bao & Jeremy N. Rich. (2019) Cancer Stem Cells: The Architects of the Tumor Ecosystem. Cell Stem Cell 24:1, pages 41-53.
Crossref
Mokgadi Violet Gwangwa, Anna Margaretha Joubert & Michelle Helen Visagie. (2018) Crosstalk between the Warburg effect, redox regulation and autophagy induction in tumourigenesis. Cellular & Molecular Biology Letters 23:1.
Crossref
Cristian Scatena, Manuela Roncella, Antonello Di Paolo, Paolo Aretini, Michele Menicagli, Giovanni Fanelli, Carolina Marini, Chiara Maria Mazzanti, Matteo Ghilli, Federica Sotgia, Michael P. Lisanti & Antonio Giuseppe Naccarato. (2018) Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study. Frontiers in Oncology 8.
Crossref
Maushmi S. Kumar & Kaveri M. Adki. (2018) Marine natural products for multi-targeted cancer treatment: A future insight. Biomedicine & Pharmacotherapy 105, pages 233-245.
Crossref
Anna-Luisa Luger, Benedikt Sauer, Nadja Lorenz, Anna Engel, Yannick Braun, Martin Voss, Patrick Harter, Joachim Steinbach & Michael Ronellenfitsch. (2018) Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems. International Journal of Molecular Sciences 19:5, pages 1504.
Crossref
Meng Liu, Shiyang Shen, Di Wen, Mengru Li, Teng Li, Xiaojie Chen, Zhen Gu & Ran Mo. (2018) Hierarchical Nanoassemblies-Assisted Combinational Delivery of Cytotoxic Protein and Antibiotic for Cancer Treatment. Nano Letters 18:4, pages 2294-2303.
Crossref
Matilde E. LleonartEtna AbadDmitry GraiferAlex Lyakhovich. (2018) Reactive Oxygen Species-Mediated Autophagy Defines the Fate of Cancer Stem Cells. Antioxidants & Redox Signaling 28:11, pages 1066-1079.
Crossref
Maciej Danielewski, Dorota Ksiądzyna & Adam Szeląg. (2018) NON-ANTIBIOTIC USE OF ANTIBIOTICS. Postępy Mikrobiologii - Advancements of Microbiology 57:4, pages 301-312.
Crossref
Bakiye Goker Bagca & Cigir Biray Avci. 2018. Autophagy in Health and Disease. Autophagy in Health and Disease 163 177 .
Bipasha Bose, Utsav Sen & Sudheer Shenoy P. (2017) Breast Cancer Stem Cell Therapeutics, Multiple Strategies Versus Using Engineered Mesenchymal Stem Cells With Notch Inhibitory Properties: Possibilities and Perspectives. Journal of Cellular Biochemistry 119:1, pages 141-149.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.